Drug rep 'tea and biscuits' not the issue, says AMA

The AMA has warned that a pharma industry proposal to publicly name doctors who accept drug company payments and hospitality has the potential to breach doctors’ rights to privacy.

The body dismissed one of the proposal options to expose doctors who accept "tea and biscuit" benefits from drug company reps, arguing that larger payments to doctors are of greater interest to patients.

The controversial proposal has been put out for debate by the pharmaceutical industry group Medicines Australia, which plans to publish details of payments to health professionals relating to prescription medicines from 2016 onwards.